Global Consortium for Biomarker Standardization
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2010
- Initiating Organization: Alzheimer's Association
- Initiator Type: Nonprofit foundation
- Disease focus:
Alzheimer's Disease - Location: North America
Abstract
The Alzheimer’s Association has established the Global Consortium for Biomarker Standardization to gather key researchers, clinicians, and industry, regulatory, and government leaders in Alzheimer’s disease (AD) to achieve consensus on the best ways to standardize and validate biomarker tests for use in clinical practices around the world.
Mission
The Consortium will continue to grow and expand as the field identifies novel technologies and techniques for diagnosis of AD. To date, projects are addressing the following:
Impact/Accomplishment
July 7, 2011: Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, et al. Alzheimer’s & Dementia. The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers.
Homepage |
http://www.alz.org/research/funding/global_biomarker_consortium.asp |
Points of Contact
Maria C. Carrillo, Ph.D.
Vice President, Medical & Scientific Relations
Alzheimer's Association
email: maria.carrillo@alz.org
Sponsors & Partners
Alzheimer's Association |